The latest research from Fore Pharma, Global Ankylosing Spondylitis Market and Competitive Landscape – 2020, provides comprehensive insights into Ankylosing Spondylitis pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecast Ankylosing Spondylitis market size and drug sales. It also provides insights into Ankylosing Spondylitis epidemiology and late stage pipeline.
This research covers the following – Ankylosing Spondylitis treatment options, Ankylosing Spondylitis late stage clinical trials pipeline, Ankylosing Spondylitis prevalence by countries, Ankylosing Spondylitis market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries US, Germany, France, Italy, Spain, UK, Japan, Europe, Global (G7 Countries).
Research Scope:
– Countries: US, Germany, France, Italy, Spain, UK, Japan, Europe, Global
– Ankylosing Spondylitis pipeline: Find out drugs in clinical trials for Ankylosing Spondylitis by development phase 3, phase 2, and phase 1, by pharmacological class and company
– Ankylosing Spondylitis epidemiology: Find out number of patients diagnosed (prevalence) with Ankylosing Spondylitis by countries
– Ankylosing Spondylitis drugs: Identify key drugs marketed and prescribed for Ankylosing Spondylitis by countries, including trade name, molecule name, and company
– Ankylosing Spondylitis drugs sales: Find out the sales value for Ankylosing Spondylitis drugs by countries
– Ankylosing Spondylitis market valuations: Find out the market size for Ankylosing Spondylitis drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2025
– Ankylosing Spondylitis drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research: The research helps executives to
– Evaluate commercial market opportunities for Ankylosing Spondylitis drugs
– Synthesize insights for business development & licensing
– Track market size, competitor drug sales, market shares in Ankylosing Spondylitis market
– Develop in-depth knowledge of competition and markets
– Analyze Ankylosing Spondylitis drug sales data to update your brand planning trackers
– Develop tactics and strategies to take advantage of opportunities in the market
– Track Market Events and Trends and analyze key events in Ankylosing Spondylitis market
– Develop forecast models, healthcare frameworks, or economic models
– Answer key business questions; supports decision making in R&D to long term marketing strategies
Table of Contents
1. Ankylosing Spondylitis Treatment Options
2. Ankylosing Spondylitis Pipeline Insights
2.1. Ankylosing Spondylitis Phase 3 Clinical Trials
2.2. Ankylosing Spondylitis Phase 2 Clinical Trials
2.3. Ankylosing Spondylitis Phase 1 Clinical Trials
3. Ankylosing Spondylitis Epidemiology Analysis by Countries
4. US Ankylosing Spondylitis Market Insights
4.1. Marketed Drugs for Ankylosing Spondylitis in US
4.2. US Ankylosing Spondylitis Market Size & Forecast
4.3. US Ankylosing Spondylitis Drugs Sales & Forecast
4.4. US Ankylosing Spondylitis Market Share Analysis
5. Germany Ankylosing Spondylitis Market Insights
5.1. Marketed Drugs for Ankylosing Spondylitis in Germany
5.2. Germany Ankylosing Spondylitis Market Size & Forecast
5.3. Germany Ankylosing Spondylitis Drugs Sales Forecast
5.4. Germany Ankylosing Spondylitis Market Share Analysis
6. France Ankylosing Spondylitis Market Insights
6.1. Marketed Drugs for Ankylosing Spondylitis in France
6.2. France Ankylosing Spondylitis Market Size & Forecast
6.3. France Ankylosing Spondylitis Product Sales Forecast
6.4. France Ankylosing Spondylitis Market Share Analysis
7. Italy Ankylosing Spondylitis Market Insights
7.1. Marketed Drugs for Ankylosing Spondylitis in Italy
7.2. Italy Ankylosing Spondylitis Market Size & Forecast
7.3. Italy Ankylosing Spondylitis Product Sales Forecast
7.4. Italy Ankylosing Spondylitis Market Share Analysis
8. Spain Ankylosing Spondylitis Market Insights
8.1. Marketed Drugs for Ankylosing Spondylitis in Spain
8.2. Spain Ankylosing Spondylitis Market Size & Forecast
8.3. Spain Ankylosing Spondylitis Product Sales Forecast
8.4. Spain Ankylosing Spondylitis Market Share Analysis
9. UK Ankylosing Spondylitis Market Insights
9.1. Marketed Drugs for Ankylosing Spondylitis in UK
9.2. UK Ankylosing Spondylitis Market Size & Forecast
9.3. UK Ankylosing Spondylitis Product Sales Forecast
9.4. UK Ankylosing Spondylitis Market Share Analysis
10. Europe Ankylosing Spondylitis Market Insights
10.1. Europe Ankylosing Spondylitis Market Size & Forecast
10.2. Europe Ankylosing Spondylitis Product Sales Forecast
10.3. Europe Ankylosing Spondylitis Market Share Analysis
11. Japan Ankylosing Spondylitis Market Insights
11.1. Marketed Drugs for Ankylosing Spondylitis in Japan
11.2. Japan Ankylosing Spondylitis Market Size & Forecast
11.3. Japan Ankylosing Spondylitis Product Sales Forecast
11.4. Japan Ankylosing Spondylitis Market Share Analysis
12. Global Ankylosing Spondylitis Market Insights
12.1. Global Ankylosing Spondylitis Market Size & Forecast
12.2. Global Ankylosing Spondylitis Product Sales Forecast
12.3. Global Ankylosing Spondylitis Market Share Analysis
13. Research Methodology
List of Tables
1: Ankylosing Spondylitis Phase 3 Clinical Trials, Global, 2020
2: Ankylosing Spondylitis Phase 2 Clinical Trials, Global, 2020
3: Ankylosing Spondylitis Phase 1 Clinical Trials, Global, 2020
4: Ankylosing Spondylitis Prevalence by Countries, 2016 – 2025
5: Marketed Drugs for Ankylosing Spondylitis in US, 2019
6: US Ankylosing Spondylitis Market Size & Forecast ($mn), 2016 – 2025
7: US Ankylosing Spondylitis Product Sales ($mn), 2016 – 2025
8: US Ankylosing Spondylitis Market Events and Trends, 2016 – 2025
9: Marketed Drugs for Ankylosing Spondylitis in Germany, 2019
10: Germany Ankylosing Spondylitis Market Size & Forecast ($mn), 2016 – 2025
11: Germany Ankylosing Spondylitis Product Sales ($mn), 2016 – 2025
12: Germany Ankylosing Spondylitis Market Events and Trends, 2016 – 2025
13: Marketed Drugs for Ankylosing Spondylitis in France, 2019
14: France Ankylosing Spondylitis Market Size & Forecast ($mn), 2016 – 2025
15: France Ankylosing Spondylitis Product Sales ($mn), 2016 – 2025
16: France Ankylosing Spondylitis Market Events and Trends, 2016 – 2025
17: Marketed Drugs for Ankylosing Spondylitis in Italy, 2019
18: Italy Ankylosing Spondylitis Market Size & Forecast ($mn), 2016 – 2025
19: Italy Ankylosing Spondylitis Product Sales ($mn), 2016 – 2025
20: Italy Ankylosing Spondylitis Market Events and Trends, 2016 – 2025
21: Marketed Drugs for Ankylosing Spondylitis in Spain, 2019
22: Spain Ankylosing Spondylitis Market Size & Forecast ($mn), 2016 – 2025
23: Spain Ankylosing Spondylitis Product Sales ($mn), 2016 – 2025
24: Spain Ankylosing Spondylitis Market Events and Trends, 2016 – 2025
25: Marketed Drugs for Ankylosing Spondylitis in UK, 2019
26: UK Ankylosing Spondylitis Market Size & Forecast ($mn), 2016 – 2025
27: UK Ankylosing Spondylitis Product Sales ($mn), 2016 – 2025
28: UK Ankylosing Spondylitis Market Events and Trends, 2016 – 2025
29: Europe Ankylosing Spondylitis Market Size & Forecast ($mn), 2016 – 2025
30: Europe Ankylosing Spondylitis Product Sales ($mn), 2016 – 2025
31: Marketed Drugs for Ankylosing Spondylitis in Japan, 2019
32: Japan Ankylosing Spondylitis Market Size & Forecast ($mn), 2016 – 2025
33: Japan Ankylosing Spondylitis Product Sales ($mn), 2016 – 2025
34: Japan Ankylosing Spondylitis Market Events and Trends, 2016 – 2025
35: Global Ankylosing Spondylitis Market Size & Forecast ($mn), 2016 – 2025
36: Global Ankylosing Spondylitis Product Sales ($mn), 2016 – 2025
List of Figures
1: Ankylosing Spondylitis Pipeline by Phase (%), Global, 2020
2: Ankylosing Spondylitis Prevalence by Countries, 2016 – 2025
3: US Ankylosing Spondylitis Market Size ($mn), 2016 – 2025
4: US Ankylosing Spondylitis Product Sales ($mn), 2016 – 2025
5: US Ankylosing Spondylitis Market Share by Drugs (%), 2019
6: US Ankylosing Spondylitis Market – Future Market Share (%), 2025
7: Germany Ankylosing Spondylitis Market Size ($mn), 2016 – 2025
8: Germany Ankylosing Spondylitis Product Sales ($mn), 2016 – 2025
9: Germany Ankylosing Spondylitis Market Share by Drugs (%), 2019
10: Germany Ankylosing Spondylitis Market – Future Market Share (%), 2025
11: France Ankylosing Spondylitis Market Size ($mn), 2016 – 2025
12: France Ankylosing Spondylitis Product Sales ($mn), 2016 – 2025
13: France Ankylosing Spondylitis Market Share by Drugs (%), 2019
14: France Ankylosing Spondylitis Market – Future Market Share (%), 2025
15: Italy Ankylosing Spondylitis Market Size ($mn), 2016 – 2025
16: Italy Ankylosing Spondylitis Product Sales ($mn), 2016 – 2025
17: Italy Ankylosing Spondylitis Market Share by Drugs (%), 2019
18: Italy Ankylosing Spondylitis Market – Future Market Share (%), 2025
19: Spain Ankylosing Spondylitis Market Size ($mn), 2016 – 2025
20: Spain Ankylosing Spondylitis Product Sales ($mn), 2016 – 2025
21: Spain Ankylosing Spondylitis Market Share by Drugs (%), 2019
22: Spain Ankylosing Spondylitis Market – Future Market Share (%), 2025
23: UK Ankylosing Spondylitis Market Size ($mn), 2016 – 2025
24: UK Ankylosing Spondylitis Product Sales ($mn), 2016 – 2025
25: UK Ankylosing Spondylitis Market Share by Drugs (%), 2019
26: UK Ankylosing Spondylitis Market – Future Market Share (%), 2025
27: Europe Ankylosing Spondylitis Market Size ($mn), 2016 – 2025
28: Europe Ankylosing Spondylitis Product Sales ($mn), 2016 – 2025
29: Europe Ankylosing Spondylitis Market Share by Drugs (%), 2019
30: Europe Ankylosing Spondylitis Market – Future Market Share (%), 2025
31: Japan Ankylosing Spondylitis Market Size ($mn), 2016 – 2025
32: Japan Ankylosing Spondylitis Product Sales ($mn), 2016 – 2025
33: Japan Ankylosing Spondylitis Market Share by Drugs (%), 2019
34: Japan Ankylosing Spondylitis Market – Future Market Share (%), 2025
35: Global Ankylosing Spondylitis Market Size ($mn), 2016 – 2025
36: Global Ankylosing Spondylitis Product Sales ($mn), 2016 – 2025
37: Global Ankylosing Spondylitis Market Share by Drugs (%), 2019
38: Global Ankylosing Spondylitis Market – Future Market Share (%), 2025
Format
Dispatch format is XLSX.